Patents Assigned to 3 D'Art
-
Publication number: 20230149598Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.Type: ApplicationFiled: November 6, 2022Publication date: May 18, 2023Applicant: 3-D Matrix, Ltd.Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
-
Publication number: 20230149599Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.Type: ApplicationFiled: December 2, 2022Publication date: May 18, 2023Applicant: 3-D Matrix, Ltd.Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
-
Patent number: 11617778Abstract: Provided herein are ionic self-assembling peptides, pharmaceutical compositions comprising the peptides, and methods of using and making the same.Type: GrantFiled: July 3, 2019Date of Patent: April 4, 2023Assignee: 3-D Matrix, Ltd.Inventors: Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
-
Patent number: 11534528Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.Type: GrantFiled: March 30, 2021Date of Patent: December 27, 2022Assignee: 3-D Matrix, Ltd.Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
-
Patent number: 11503991Abstract: Embodiments of the present invention may be used to perform measurement of surfaces, such as external and internal surfaces of the human body, in full-field and in 3-D. Embodiments of the present invention may include an electromagnetic radiation source, which may be configured to project electromagnetic radiation onto a surface. The electromagnetic radiation source may be configured to project the electromagnetic radiation in a pattern corresponding to a spatial signal modulation algorithm. The electromagnetic radiation source may also be configured to project the electromagnetic radiation at a frequency suitable for transmission through the media in which the radiation is projected. An image sensor may be configured to capture image data representing the projected pattern.Type: GrantFiled: February 27, 2020Date of Patent: November 22, 2022Assignee: Virtual 3-D Technologies Corp.Inventor: Robert Zeien
-
Patent number: 11497833Abstract: Compositions, peptide solutions and macroscopic scaffolds of self-assembling peptides consisting essentially of non-ionic, polar amino acids are provided. Particular peptides include those comprising, or consisting essentially of, serine, threonine, tyrosine, cysteine, glutamine, asparagine, methionine, tryptophan, hydroxy-proline, and combinations thereof. Methods of sterilizing the self-assembling peptides, and scaffolds comprising the peptides are also provided.Type: GrantFiled: May 4, 2020Date of Patent: November 15, 2022Assignee: 3-D Matrix, Ltd.Inventors: Eun Seok Gil, Marika Rioult, Keiji Nagano, Karl Patrick Gilbert, Toshiro Kiyofuji, Yuya Hasegawa
-
Publication number: 20220168462Abstract: Systems and methods of blocking a biological vessel 2 are provided. The systems and methods may comprise introducing to the vessel an amphiphilic peptide. The peptide may comprise at least thirteen amino acids that may alternate between a hydrophobic amino acid and a hydrophilic amino acid. The peptide may form a beta- sheet spontaneously in an aqueous solution in the presence of a cation.Type: ApplicationFiled: November 24, 2021Publication date: June 2, 2022Applicant: 3-D Matrix, Ltd.Inventors: Satoru Kobayashi, Kentaro Takamura
-
Patent number: 11324703Abstract: Disclosed herein are surfactant peptide nanostructures wherein the peptides have repeating hydrophobic amino acids in an integer equal to or less than four. The peptide nanostructures are useful for therapeutic applications, including for delivery of drugs and siRNA.Type: GrantFiled: November 30, 2018Date of Patent: May 10, 2022Assignee: 3-D Matrix, Ltd.Inventors: Eun Seok Gil, Elton Aleksi, Noriaki Matsuda
-
Publication number: 20220111126Abstract: Methods and materials for mitigating biological tissue adhesion are described herein. One method for mitigating adhesion to a biological tissue includes administering an effective amount of a self-assembling peptide solution to the biological tissue, wherein the self-assembling peptide is between about 7 amino acids and 32 amino acids in length and the self-assembling peptide solution forms a hydrogel under physiological conditions.Type: ApplicationFiled: November 5, 2021Publication date: April 14, 2022Applicant: 3-D Matrix, Ltd.Inventors: Satoru Kobayashi, Eun Seok Gil, Lisa Spirio
-
Patent number: 11298397Abstract: [Problem] To provide a composition for hemostasis that can be applied uniformly to a bleeding site and exerts a high hemostatic effect. [Solution] Provided is a composition to be applied to the subject as a spray, wherein the composition is characterized in that the spray is for hemostasis, and the composition includes a self-assembling peptide, the self-assembling peptide gelling due to self-assembly when the composition is applied to the bleeding site of the subject, and the self-assembling peptide being included in the composition in a concentration having an improved hemostatic capacity in comparison to direct application.Type: GrantFiled: December 14, 2016Date of Patent: April 12, 2022Assignee: 3-D Matrix, Ltd.Inventors: Keiji Nagano, Satoru Kobayashi
-
Patent number: 11260072Abstract: Provided are methods and compositions useful in the diagnosis, treatment, and monitoring of osteosarcoma. Antisense to certain microRNA (miRNA) found to be associated with cancer stem cells (CSCs) or tumor-initiating cells (TICs) of osteosarcoma are useful to suppress tumor growth and metastasis, and prolong survival. Antisense oligonucleotides to miR-133a are synergistic in combination with standard chemotherapy such as cisplatin in the treatment of osteosarcoma.Type: GrantFiled: April 4, 2019Date of Patent: March 1, 2022Assignee: 3-D Matrix, Ltd.Inventors: Takahiro Ochiya, Tomohiro Fujiwara
-
Patent number: 11153696Abstract: Systems and methods are disclosed for making three-dimensional models of the inside of an ear canal using a projected pattern. A system comprises a probe adapted to be inserted into the ear canal. The probe comprises a narrow portion adapted to fit inside the ear canal and a wide portion adapted to be wider than the ear canal, which may be formed by a tapered stop. An illumination subsystem projects a pattern of light from the distal end of the probe onto a surface of the ear canal, the pattern being modulated by the three-dimensional surface of the ear canal. An imaging subsystem captures a series of individual images of the pattern of light projected onto the surface of the ear canal. A computer subsystem calculates digital three-dimensional representations from the individual images and stitches them together to generate a digital three-dimensional model of the ear canal.Type: GrantFiled: February 12, 2018Date of Patent: October 19, 2021Assignee: VIRTUAL 3-D TECHNOLOGIES CORP.Inventor: Robert Zeien
-
Publication number: 20210299326Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.Type: ApplicationFiled: March 30, 2021Publication date: September 30, 2021Applicant: 3-D Matrix, Ltd.Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
-
Patent number: 11090398Abstract: Methods and devices for sterilizing viscous peptide compositions which have shear thinning rheological properties at high concentrations.Type: GrantFiled: October 26, 2018Date of Patent: August 17, 2021Assignee: 3-D Matrix, Ltd.Inventors: Eun Seok Gil, Karl Patrick Gilbert
-
Publication number: 20210215713Abstract: The present invention to a method, a kit, etc., for predicting the response BNCT using a BSH-related medicine-containing boron preparation and a BPA-containing boron preparation, the method and kit being characterized by examining the expression of CD44, a translation-related factor and/or LAT1 in cancer cells of a sample. When the expression of the CD44 or translation-related factor in the cancer cells of the sample is high, it can be predicted that the BNCT using the BSSH-related medicine-containing boron preparation is likely to be responsive. When the expression of the LAT1 in the cancer cells of the sample is high, it can be predicted that the BNCT using the BPA-containing boron preparation is likely to be responsive.Type: ApplicationFiled: February 8, 2019Publication date: July 15, 2021Applicant: 3-D MATRIX, LTD.Inventors: Hideki MATSUI, Atsushi FUJIMURA
-
Patent number: 10961274Abstract: Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion are provided herein. Compositions, peptide solutions and macroscopic scaffolds of self-assembling peptides consisting essentially of non-ionic, polar amino acids are provided to prevent adhesion or to provide anti-adhesion properties. Particular peptides include those consisting essentially of, serine, threonine, tyrosine, cysteine, glutamine, asparagine, methionine, tryptophan, hydroxy-proline, and combinations thereof. Methods and kits are also provided.Type: GrantFiled: December 15, 2016Date of Patent: March 30, 2021Assignee: 3-D Matrix, Ltd.Inventors: Eun Seok Gil, Marc Rioult, Keiji Nagano, Karl Patrick Gilbert, Toshiro Kiyofuji, Yuya Hasegawa
-
Patent number: 10876689Abstract: A lighting tube for uniform illumination is disclosed. The lighting tube includes a conduit having an inner layer, outer layer, and a middle layer between the inner and outer layers. The middle layer has at least two of a phosphor film, a diffusion film, and a UV-blocking film. The lighting tube also includes a light emitting chain located inside of the conduit. The light emitting chain includes control wires and a plurality of light emitting units spaced along the control wires. Each unit has a plurality of faces interconnected to form a polygon when viewed along a central axis, with each face being on a different side of the polygon. Each face has an LED coupled to the control wires. The LED emits light with a wavelength that causes the phosphor film to luminesce. The illumination of the middle layer by the chain is substantially uniform in all radial directions.Type: GrantFiled: December 12, 2019Date of Patent: December 29, 2020Assignee: Retinal 3-D, L.L.C.Inventor: Roger C. Bowser
-
Patent number: 10835637Abstract: The present invention relates to a triblock copolymer having a polyethylene glycol-poly(D,L-lactide)-polyethylene glycol skeleton.Type: GrantFiled: August 23, 2016Date of Patent: November 17, 2020Assignees: 3-D Matrix, Ltd. (Tokyo, Japan), Tokyo University of Science FoundationInventors: Hidenori Otsuka, Daisuke Matsukuma, Noriaki Matsuda
-
Patent number: 10814038Abstract: Combination compositions comprising self-assembling peptides and payload agents, and methods of making and using such compositions, are described.Type: GrantFiled: December 29, 2016Date of Patent: October 27, 2020Assignees: 3-D Matrix, Ltd., Vicus Therapeutics, LLCInventors: John Maki, Eun Seok Gil, Lisa Spirio
-
Patent number: 10793307Abstract: The enclosed disclosure describes, among other things, a method including the steps of a first deaerating step in which a mixture comprising peptides is deaerated by lowering the pressure, filtering the mixture through a sterilizing filter; and a second deaerating step, in which the filtrate is deaerated by vibration and lowering the pressure.Type: GrantFiled: July 3, 2013Date of Patent: October 6, 2020Assignee: 3-D Matrix, Ltd.Inventors: Masahiro Nohara, Yuya Hasegawa